GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Ray Medicine International Holding Ltd (HKSE:06108) » Definitions » Net Margin %

New Ray Medicine International Holding (HKSE:06108) Net Margin % : 38.51% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is New Ray Medicine International Holding Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. New Ray Medicine International Holding's Net Income for the six months ended in Dec. 2023 was HK$-8.81 Mil. New Ray Medicine International Holding's Revenue for the six months ended in Dec. 2023 was HK$-22.89 Mil. Therefore, New Ray Medicine International Holding's net margin for the quarter that ended in Dec. 2023 was 38.51%.

The historical rank and industry rank for New Ray Medicine International Holding's Net Margin % or its related term are showing as below:

HKSE:06108' s Net Margin % Range Over the Past 10 Years
Min: -86.83   Med: -23.13   Max: 14.34
Current: -44.2


HKSE:06108's Net Margin % is ranked worse than
83.74% of 652 companies
in the Healthcare Providers & Services industry
Industry Median: 1.66 vs HKSE:06108: -44.20

New Ray Medicine International Holding Net Margin % Historical Data

The historical data trend for New Ray Medicine International Holding's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Ray Medicine International Holding Net Margin % Chart

New Ray Medicine International Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.18 -52.35 -0.84 -86.83 -44.20

New Ray Medicine International Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.27 -36.05 -185.61 -18.29 38.51

Competitive Comparison of New Ray Medicine International Holding's Net Margin %

For the Pharmaceutical Retailers subindustry, New Ray Medicine International Holding's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Ray Medicine International Holding's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Ray Medicine International Holding's Net Margin % distribution charts can be found below:

* The bar in red indicates where New Ray Medicine International Holding's Net Margin % falls into.



New Ray Medicine International Holding Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

New Ray Medicine International Holding's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-22.17/50.154
=-44.20 %

New Ray Medicine International Holding's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-8.813/-22.885
=38.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


New Ray Medicine International Holding  (HKSE:06108) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


New Ray Medicine International Holding Net Margin % Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


New Ray Medicine International Holding (HKSE:06108) Business Description

Traded in Other Exchanges
N/A
Address
19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN
New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.

New Ray Medicine International Holding (HKSE:06108) Headlines

No Headlines